ZAS Corporation Hosts Virtual CME on Kidney Transplant Induction Therapy
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted […]
ZAS Corporation Showcases Commitment to Oncology Care at MOSB Congress 2024
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The
ZAS Corporation Proudly Sponsors the 178th World Anesthesia Day Celebration with Bangladesh Society of Anaesthesiologists, Critical Care and Pain Physicians.
ZAS Corporation was honored to serve as the core sponsor of the 178th World Anesthesia Day celebration, organized by the
ZAS Corporation Celebrates 19th Anniversary with Team Participation
ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation, and growth. The milestone event saw
Morinaga Research Centre Japan Visits Bangladesh to Strengthening Global Collaborations
We are thrilled to have welcomed our partners from the Morinaga Research Centre, Japan, to Bangladesh. This visit signifies a
ZAS Gyno Sales Team Concludes Inspiring ‘Sales Summit – Recharge & Rise’ Conference
ZAS Gyno, a division of ZAS Corporation Ltd., recently held an empowering sales conference titled “Sales Summit – Recharge &
ZAS Corporation Obtains Trademark for Protimeal Brand
We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark
ZAS Corporation Secures Trademark for DECA Brand
We are proud to announce that ZAS Corporation Ltd. has officially secured the trademark for our brand DECA. Registered under
ZAS Corporation Successfully Launches Celltrion Biosimilars in Bangladesh
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our
ZAS Corporation Ltd. Unveils Vision for the Next Decade in Oncology at Sales Conference
Dhaka, Bangladesh – ZAS Corporation Ltd., a leading pharmaceutical company with a strong focus on oncology, recently held a transformative